Real Chemistry Executive and Leadership Team

July, 2026

Leadership Overview

Real Chemistry has 10 executives leading key functions including finance, marketing, revenue, operations, technology, earned media, international growth, communications, strategy, and scientific visualization.

Driven by innovation, Real Chemistry is dedicated to creating AI-powered, idea-driven healthcare experiences with the customer at the center, propelling the commercial success of healthcare companies.

Leadership Roles at Real Chemistry

  • Chief Financial Officer - Jeffrey Lupinacci
  • Chief Operating Officer & Chief Technology Officer - Jeffrey O'Connell
  • Group President and Chief Revenue Officer - Jj Schmuckler
  • President, Earned Media - Becky Vonsiatsky
  • Group President, International Growth - Kath Harrison
  • Group President and Managing Partner - Kevin Johnson
  • President & Communications & Corporate Strategy Executive - Shoreen Maghame
  • President, Scientific Visualization - Brandon Pletsch
  • President, Medical Communications (US) - Cali Howitt
  • Chief Marketing Officer - Ericka McKenna
  • Jeffrey Lupinacci - Chief Financial Officer

    Jeffrey Lupinacci, the Chief Financial Officer at Real Chemistry, directs the company's financial strategy and operations. Overseeing all fiscal activities, Lupinacci ensures robust financial planning, accurate reporting, and effective resource allocation to support Real Chemistry's growth objectives. This leadership role involves managing budgets, forecasting financial performance, and optimizing capital structure to drive profitability and shareholder value. By maintaining strong relationships with financial institutions and investors, Jeffrey Lupinacci secures the necessary capital for strategic initiatives and operational expansion. The Chief Financial Officer's purview extends to risk management, ensuring compliance with financial regulations, and implementing financial controls that safeguard company assets. This executive's focus on financial health directly underpins the company's ability to deliver AI-powered healthcare experiences.
    Jeffrey Lupinacci

    Jeffrey O'Connell - Chief Operating Officer & Chief Technology Officer

    Jeffrey O'Connell, the Chief Operating Officer & Chief Technology Officer at Real Chemistry, oversees the company's operational efficiency and technological innovation. O'Connell directs the development and implementation of AI-powered platforms and infrastructure, ensuring seamless delivery of healthcare experiences. This dual role involves optimizing internal processes, managing IT resources, and driving technological advancements that support Real Chemistry's strategic objectives. The Chief Operating Officer & Chief Technology Officer collaborates with cross-functional teams to enhance operational scalability and maintain high standards of service delivery. By leveraging cutting-edge technology, Jeffrey O'Connell ensures that Real Chemistry remains at the forefront of innovation in the healthcare marketing sector. This executive's leadership is pivotal in translating complex technological capabilities into tangible business outcomes for clients.

    Jj Schmuckler - Group President and Chief Revenue Officer

    Jj Schmuckler, the Group President and Chief Revenue Officer at Real Chemistry, spearheads the company's revenue generation and client relationship management across key markets. Schmuckler directs sales operations, business development, and account management functions, ensuring alignment with Real Chemistry's mission to drive commercial success in healthcare. This leadership position involves cultivating strategic partnerships and expanding the company's client base through innovative healthcare solutions. The Group President and Chief Revenue Officer works to optimize the entire revenue funnel, from lead generation to client retention, focusing on delivering measurable value. By understanding market dynamics and client needs, Jj Schmuckler drives growth initiatives and enhances the company's market presence. This executive's strategic oversight ensures that Real Chemistry consistently meets and exceeds revenue targets.
    Jj Schmuckler

    Becky Vonsiatsky - President, Earned Media

    Becky Vonsiatsky, the President, Earned Media at Real Chemistry, leads the strategic development and execution of earned media initiatives. Vonsiatsky directs public relations, media relations, and influencer engagement strategies designed to enhance Real Chemistry's reputation and amplify its message within the healthcare industry. This role focuses on building credibility and driving organic reach through compelling storytelling and impactful media placements. The President, Earned Media collaborates with marketing and communications teams to ensure consistent brand messaging across all earned channels. By identifying key media opportunities and cultivating strong relationships with journalists and influencers, Becky Vonsiatsky elevates the company's profile. This executive's expertise is crucial in shaping public perception and generating positive media coverage for Real Chemistry's innovative healthcare solutions.

    Kath Harrison - Group President, International Growth

    Kath Harrison, the Group President, International Growth at Real Chemistry, drives the expansion of the company's services and client base across global markets. Harrison oversees the strategic planning and execution of international business development initiatives, identifying new opportunities and adapting Real Chemistry's AI-powered solutions to diverse regional needs. This leadership role involves building and managing international teams, fostering key partnerships, and ensuring operational readiness in new territories. The Group President, International Growth works to establish Real Chemistry's presence and impact in regions outside its primary markets, contributing significantly to overall company expansion. By navigating complex international landscapes, Kath Harrison ensures that Real Chemistry effectively serves healthcare companies worldwide, driving global commercial success.

    Kevin Johnson - Group President and Managing Partner

    Kevin Johnson, the Group President and Managing Partner at Real Chemistry, leads significant client engagements and strategic partnerships. Johnson directs key account management and business development efforts, ensuring that Real Chemistry's AI-powered healthcare experiences deliver maximum value to its partners. This role involves fostering deep client relationships and identifying opportunities for growth and innovation within existing accounts. The Group President and Managing Partner collaborates with internal teams to align service delivery with client objectives and strategic goals. By providing executive oversight and strategic guidance, Kevin Johnson ensures client satisfaction and retention. This executive's focus on partnership excellence is fundamental to Real Chemistry's mission of driving commercial success for healthcare companies.

    Shoreen Maghame - President & Communications & Corporate Strategy Executive

    Shoreen Maghame, the President & Communications & Corporate Strategy Executive at Real Chemistry, directs the company's strategic communications and overarching corporate strategy. Maghame oversees the development and implementation of communication plans that enhance Real Chemistry's brand narrative and market positioning, while also shaping the long-term strategic direction of the organization. This executive role involves aligning internal and external communications with business objectives and ensuring cohesive corporate messaging. The President & Communications & Corporate Strategy Executive collaborates with leadership across all departments to foster a unified strategic vision. By guiding corporate strategy and communication efforts, Shoreen Maghame ensures that Real Chemistry effectively articulates its value proposition and maintains a strong competitive edge in the healthcare industry.
    Shoreen Maghame

    Brandon Pletsch - President, Scientific Visualization

    Brandon Pletsch, the President, Scientific Visualization at Real Chemistry, leads the innovation and application of advanced visualization technologies. Pletsch directs the creation of compelling visual content that translates complex scientific data into understandable and engaging healthcare experiences for clients. This role is crucial in enhancing the communication of scientific information, supporting drug development, medical education, and patient engagement initiatives. The President, Scientific Visualization collaborates with scientific, marketing, and technology teams to ensure the accuracy and impact of visualization outputs. By pushing the boundaries of scientific visualization, Brandon Pletsch enables healthcare companies to communicate their innovations more effectively. This executive's expertise is vital in delivering Real Chemistry's promise of idea-driven, customer-centric healthcare experiences.
    Brandon Pletsch

    Cali Howitt - President, Medical Communications (US)

    Cali Howitt, the President, Medical Communications (US) at Real Chemistry, leads the company's medical communications strategy and execution within the United States. Howitt directs teams responsible for developing and disseminating accurate, compliant, and impactful medical information to healthcare professionals and stakeholders. This role focuses on ensuring that Real Chemistry's clients effectively communicate their scientific advancements and therapeutic benefits. The President, Medical Communications (US) collaborates closely with regulatory affairs, clinical development, and marketing teams to maintain scientific integrity and strategic alignment. By fostering strong relationships with key opinion leaders and medical societies, Cali Howitt enhances Real Chemistry's reputation as a trusted partner in medical communication. This executive's leadership is essential for driving successful healthcare outcomes through clear and precise communication.

    Ericka McKenna - Chief Marketing Officer

    Ericka McKenna, the Chief Marketing Officer at Real Chemistry, architects and executes the company's global marketing strategies. Driving brand awareness and market positioning, McKenna oversees all promotional activities, digital marketing campaigns, and content creation initiatives. This role is critical in communicating Real Chemistry's value proposition to healthcare companies, emphasizing its AI-powered solutions and customer-centric approach. The Chief Marketing Officer collaborates closely with sales and product development teams to ensure marketing efforts align with business goals and market demands. By analyzing market trends and customer insights, Ericka McKenna identifies new opportunities for engagement and revenue generation. This executive's leadership ensures that Real Chemistry's innovative healthcare experiences reach and resonate with the target audience, fostering strong client relationships and expanding market reach.

    Explore Leadership Teams in Advertising Networks

    Frequently Asked Questions Regarding Real Chemistry Top Executives and Leadership Team

    Who leads Real Chemistry?
    Real Chemistry is led by Jeffrey Lupinacci (Chief Financial Officer), along with executives such as Jeffrey O'Connell (Chief Operating Officer & Chief Technology Officer) and Jj Schmuckler (Group President and Chief Revenue Officer).
    Who is part of Real Chemistry’s executive team?
    The executive team of Real Chemistry includes leaders such as Jeffrey Lupinacci (Chief Financial Officer), Jeffrey O'Connell (Chief Operating Officer & Chief Technology Officer), Jj Schmuckler (Group President and Chief Revenue Officer) and other senior executives.
    How many executives does Real Chemistry have?
    Real Chemistry has 10 executives leading key business areas.
    What roles are included in Real Chemistry’s leadership team?
    The leadership team of Real Chemistry includes roles such as Chief Financial Officer, Chief Operating Officer & Chief Technology Officer, Group President and Chief Revenue Officer, President, Earned Media, Group President, International Growth.